Welcome to Cilag AG
Cilag AG is part of Janssen, the pharmaceuticals division of Johnson & Johnson*, and produces pharmaceutical and medical products and active ingredients.
The company is a strategic market launch and manufacturing location for some of Johnson & Johnson’s most important pharmaceutical products. Using state-of-the-art technologies and processes, Cilag AG produces a variety of pharmaceutical dosage forms and active chemical ingredients.
In addition, it also produces “ASP Cellblocks” and Sterrad cassettes for the Johnson & Johnson subsidiary Advanced Sterilization Products (ASP). The products are used in hospitals and labs worldwide for the sterilization of medical and surgical equipment and instruments.
Cilag AG was established in Schaffhausen in 1936 and has been part of the Johnson & Johnson Family of Companies since 1959. In the 1990s in particular, the company expanded continuously through innovation, and today Cilag AG is one of the largest manufacturers in the Swiss pharmaceuticals industry. Cilag AG employs approximately 1,200 people.
*Johnson & Johnson groups its companies operating worldwide in the pharmaceutical sector under the “Janssen Pharmaceutical Companies of Johnson & Johnson” trademark. Since October 2015, Cilag AG’s market presence has been associated with the image of the Janssen trademark. By adopting the Janssen image, Cilag takes its long-standing membership of the Johnson & Johnson Group and its strategic significance within the Janssen Pharmaceutical Companies’ supply chain into account.
We are a worldwide strategic development, launch and production center of APIs (active pharmaceutical ingredients) and drug products delivering world class performance in time-to-market, customer service, quality, cost and cash flow.
Our decisions, our attitude and all our activities are based upon the Credo. The Credo represents our core philosophy and describes the basis of the ethical values, which are valid within the entire Johnson & Johnson Organization. It represents the standards, which the employees have to follow. The Credo was written 1943 by Robert Wood Johnson, son of the company’s founder and third Chairman in a row, and only minor revisions have been made since.
We believe our first responsibility is to the doctors, nurses and patients, to mothers and fathers and all others who use our products and services. In meeting their needs everything we do must be of high quality. We must constantly strive to reduce our costs in order to maintain reasonable prices. Customers' orders must be serviced promptly and accurately. Our suppliers and distributors must have an opportunity to make a fair profit.
We are responsible to our employees, the men and women who work with us throughout the world. Everyone must be considered as an individual. We must respect their dignity and recognize their merit. They must have a sense of security in their jobs. Compensation must be fair and adequate, and working conditions clean, orderly and safe. We must be mindful of ways to help our employees fulfill their family responsibilities. Employees must feel free to make suggestions and complaints. There must be equal opportunity for employment, development and advancement for those qualified. We must provide competent management, and their actions must be just and ethical.
We are responsible to the communities in which we live and work and to the world community as well. We must be good citizens - support good works and charities and bear our fair share of taxes. We must encourage civic improvements and better health and education. We must maintain in good order the property we are privileged to use, protecting the environment and natural resources.
Our final responsibility is to our stockholders. Business must make a sound profit. We must experiment with new ideas. Research must be carried on, innovative programs developed and mistakes paid for. New equipment must be purchased, new facilities provided and new products launched. Reserves must be created to provide for adverse times. When we operate according to these principles, the stockholders should realize a fair return.
IN THE HEART OF EUROPE
Located in Switzerland’s northernmost City, Cilag AG is at the very heart of Europe. Schaffhausen is a charming place and provides a high quality of life.
Schaffhausen is known all over the world for companies like IWC Schaffhausen, Georg Fischer, Unilever and Cilag AG.
The History of Cilag AG
Dr. Bernhard Joos senior,
a medical doctor, father of the founder of Cilag AG
Dr. Bernhard Joos junior,
founder of Cilag AG
Robert Wood Johnson
(General Johnson, author of the Johnson & Johnson Credo in 1943)
In the 1930´s, the Joos family owned two stately mansions in a residential area of Schaffhausen. The many trees that surrounded the property made it look like a splendid park. This was where Dr.B. Joos lived and worked as a district and school doctor in his hometown.
In 1933 his son Dr. Bernhard Joos, a chemist by profession, returned to Schaffhausen after a long stay in the United States of America where he had spent his time improving his professional background.
Now that he had acquired specialized knowledge and new ideas, he started the development of novel medicines in a small laboratory on his father´s property. Initially, he developed a preparation he named Pyridacil®, an azo dyestuff derived from pyridine, still used today for the disinfection of the kidneys and the urinary tract.
Encouraged by his first success, in May 1936 Dr. Joos founded his own company, Cilag, which is the acronym for Chemical Industrial Laboratory AG. Dr. Carl Naegeli, a well-known professor at the University of Zurich, was elected as President of the administrative board.
Unfortunately he did not survive to see the industrial production of the experiments he had initiated as an unexpected disease forced him to end his work in 1942. Dr. Bernhard Joos himself then took over the top management as President of the administrative board until he left the company in 1949.
Only a few years after the founding of Cilag, the research team of the young company already had launched no less than six new pharmaceutical preparations. After the war in May 1945, Cilag also started to export the preparations which had been sold successfully in Switzerland until that time. This was the beginning of Cilag´s expansion into the international markets. So Cilag GmbH in Austria was founded in 1949 followed by the 1952 setup up of an affiliated company in Germany and finally in Italy Cilag SA was established during 1961.
The mansion of the family Joos served for the office of the company
In 1959, Cilag joined the major U.S. multinational company Johnson & Johnson, which is headquartered in New Brunswick, New Jersey.
Being part of Johnson & Johnson provides Cilag with access to comprehensive research. The chemical and pharmaceutical research development activities carried out in Schaffhausen also have heavily expanded.
Throughout the 90's and continuing this decade, Cilag has invested significantly to modernize its facilities and systems. Cilag is now, with 1200 employees, a strategic pharmaceutical development and manufacturing location for Johnson & Johnson.
The “Geschichte eines Schaffhauser Pharmaunternehmens” (history of a Schaffhausen pharmaceutical enterprise) was written in 2006 on the occasion of the 70th anniversary of the company’s existence.
This volume of more than 300 pages describes the remarkable growth of Cilag AG, embedded in its economic, political and technological context. The “Geschichte eines Schaffhauser Pharmaunternehmens” has been published by Chronos Verlag, Zurich, and is available in bookstores or can be obtained directly from Cilag AG.
Since October 2015, Cilag AG’s market presence has been associated with the image of the Janssen trademark. By adopting the Janssen image, Cilag takes its long-standing membership of the Johnson & Johnson Group and its strategic significance within the Janssen Pharmaceutical Companies’ supply chain into account.
Telephone: +41 52 630 91 11
Telefax: +41 52 630 94 44
This site is published by Cilag AG which is solely responsible for its content. It is intended for visitors from Switzerland.
Last update: 26.07.2018 © Cilag AG, 2001–2018